MYX 2.56% $3.81 mayne pharma group limited

delay with new doryx formulation

  1. 24 Posts.
    lightbulb Created with Sketch. 1
    The half yearly report said the delay with orders for their new formulation for Doryx makes their FY projection for EBITDA of $18.2 m no longer appropriate. EBITDA for the half year was only $5.1m.

    Anybody got an idea what the revised EBITDA will be?
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$3.81
Change
-0.100(2.56%)
Mkt cap ! $324.1M
Open High Low Value Volume
$3.96 $4.01 $3.78 $706.7K 182.5K

Buyers (Bids)

No. Vol. Price($)
2 2573 $3.80
 

Sellers (Offers)

Price($) Vol. No.
$3.83 90 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.